Sale!

DCX Gene Lissencephaly Subcortical Laminal Heterotopia X-Linked Genetic Test

Original price was: $700.Current price is: $500.

-29%

The DCX Gene Lissencephaly Subcortical Laminal Heterotopia X-Linked NGS Genetic DNA Test is a specialized genetic analysis that identifies mutations in the DCX gene responsible for severe neurological disorders affecting brain development. This comprehensive test utilizes Next Generation Sequencing technology to detect abnormalities that cause lissencephaly (smooth brain) and subcortical band heterotopia, conditions characterized by improper neuronal migration during fetal development. The test is crucial for individuals experiencing developmental delays, seizures, intellectual disabilities, or those with family history of X-linked neurological disorders. Results provide valuable information for diagnosis, treatment planning, and genetic counseling. Available for $500 USD, this test offers significant savings from the regular $700 price and provides essential insights for managing complex neurological conditions.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

DCX Gene Lissencephaly Subcortical Laminal Heterotopia X-Linked NGS Genetic DNA Test

Comprehensive Introduction to DCX Gene Testing

The DCX Gene Lissencephaly Subcortical Laminal Heterotopia X-Linked NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise detection of mutations responsible for severe brain development disorders. This advanced genetic analysis focuses on the DCX (doublecortin) gene located on the X chromosome, which plays a critical role in neuronal migration during fetal brain development. When mutations occur in this gene, they disrupt the normal formation of cerebral cortex layers, leading to conditions that significantly impact neurological function and quality of life.

Our specialized testing utilizes cutting-edge Next Generation Sequencing (NGS) technology to provide comprehensive analysis of the DCX gene, enabling early and accurate diagnosis of lissencephaly and subcortical band heterotopia. These conditions represent a spectrum of neuronal migration disorders where the brain’s surface appears abnormally smooth (lissencephaly) or shows abnormal clusters of neurons in the white matter (heterotopia). Early detection through genetic testing is essential for proper management, treatment planning, and genetic counseling for affected families.

What This Test Measures and Detects

The DCX Gene NGS Genetic DNA Test specifically targets and analyzes:

  • Complete sequencing of the DCX gene to identify point mutations, deletions, and insertions
  • X-linked inheritance patterns affecting neurological development
  • Mutations causing lissencephaly type 1 (classical lissencephaly)
  • Genetic variations leading to subcortical band heterotopia (double cortex syndrome)
  • Abnormalities in neuronal migration pathways during brain development
  • Carrier status identification in female family members

Advanced Detection Capabilities

Our NGS technology provides unparalleled sensitivity in detecting even subtle genetic variations that traditional methods might miss. The test examines all coding regions and flanking intronic sequences of the DCX gene, ensuring comprehensive coverage for accurate mutation identification. This thorough analysis helps distinguish between different types of neuronal migration disorders and provides crucial information for prognosis and management strategies.

Who Should Consider This Genetic Test

This specialized genetic testing is recommended for individuals presenting with:

  • Infants and children with developmental delays and neurological symptoms
  • Patients exhibiting seizures, especially infantile spasms
  • Individuals with intellectual disability of unknown origin
  • Abnormal brain MRI findings showing smooth brain surface or band heterotopia
  • Family history of X-linked neurological disorders
  • Females with milder neurological symptoms suggesting carrier status
  • Patients with suspected neuronal migration disorders

Clinical Indications and Symptoms

Healthcare providers should consider ordering this test when patients present with characteristic symptoms including severe developmental delay, early-onset seizures, microcephaly, feeding difficulties, and abnormal muscle tone. The test is particularly important for families with a history of X-linked inheritance patterns where males are more severely affected than females, consistent with DCX gene-related disorders.

Significant Benefits of DCX Gene Testing

Undergoing the DCX Gene Lissencephaly Subcortical Laminal Heterotopia X-Linked NGS Genetic DNA Test provides numerous advantages:

  • Accurate Diagnosis: Provides definitive genetic confirmation of neurological conditions
  • Treatment Guidance: Informs targeted therapeutic approaches and seizure management
  • Genetic Counseling: Enables informed family planning decisions
  • Prognostic Information: Helps predict disease progression and outcomes
  • Carrier Detection: Identifies female carriers for genetic counseling
  • Early Intervention: Facilitates timely developmental support services
  • Research Contribution: Advances understanding of neuronal migration disorders

Understanding Your Test Results

Our comprehensive genetic counseling team provides detailed interpretation of your DCX gene test results:

Positive Results

A positive result indicates the presence of a pathogenic mutation in the DCX gene, confirming the diagnosis of DCX-related neuronal migration disorder. This information allows for:

  • Implementation of appropriate seizure management strategies
  • Development of individualized educational and therapeutic plans
  • Genetic counseling for family members regarding inheritance risks
  • Connection with specialized neurological care teams

Negative Results

A negative result suggests that DCX gene mutations are not the cause of the neurological symptoms, guiding physicians toward alternative diagnostic considerations and additional testing if needed.

Variant of Uncertain Significance

In some cases, genetic variations of unknown clinical significance may be identified. Our genetic specialists provide ongoing monitoring and reclassification as new research emerges.

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $500
Regular Price $700

Test Specifications

  • Turnaround Time: 3 to 4 Weeks
  • Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
  • Testing Method: Next Generation Sequencing (NGS) Technology
  • Specialty: Neurology and Genetics
  • Department: Genetics
  • Disease Type: Neurological Disorders

Pre-Test Requirements

Before testing, we require:

  • Complete clinical history of the patient
  • Genetic counseling session to create a detailed family pedigree
  • Documentation of affected family members with similar neurological conditions
  • Recent neurological evaluations and imaging studies when available

Nationwide Accessibility

We have diagnostic centers conveniently located across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, San Francisco, and many other cities. Our network ensures that advanced genetic testing is accessible to patients nationwide.

Take Action Today

Don’t wait to get the answers you need for proper neurological care. Our experienced genetic counselors and neurological specialists are ready to guide you through the testing process and provide comprehensive support.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your DCX Gene Lissencephaly Subcortical Laminal Heterotopia X-Linked NGS Genetic DNA Test appointment. Take the first step toward accurate diagnosis and effective management of neurological conditions affecting brain development.

Early genetic testing can make a significant difference in treatment outcomes and quality of life for individuals with neuronal migration disorders. Contact us now to begin your journey toward comprehensive neurological genetic care.